NO992907L - Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling - Google Patents

Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling

Info

Publication number
NO992907L
NO992907L NO992907A NO992907A NO992907L NO 992907 L NO992907 L NO 992907L NO 992907 A NO992907 A NO 992907A NO 992907 A NO992907 A NO 992907A NO 992907 L NO992907 L NO 992907L
Authority
NO
Norway
Prior art keywords
preparation
buprenorphine
release
application
oral cavity
Prior art date
Application number
NO992907A
Other languages
English (en)
Norwegian (no)
Other versions
NO992907D0 (no
Inventor
Karsten Cremer
Henrik Luessen
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO992907D0 publication Critical patent/NO992907D0/no
Publication of NO992907L publication Critical patent/NO992907L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO992907A 1996-12-16 1999-06-14 Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling NO992907L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652188A DE19652188C2 (de) 1996-12-16 1996-12-16 Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
PCT/EP1997/006369 WO1998026780A2 (de) 1996-12-16 1997-11-14 Flache arzneizubereitung zur applikation und freisetzung von buprenorphin oder einer pharmakologisch vergleichbaren substanz in der mundhöhle und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO992907D0 NO992907D0 (no) 1999-06-14
NO992907L true NO992907L (no) 1999-06-14

Family

ID=7814805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992907A NO992907L (no) 1996-12-16 1999-06-14 Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling

Country Status (12)

Country Link
EP (1) EP0949925B1 (es)
JP (2) JP2001506640A (es)
KR (1) KR100514306B1 (es)
AT (1) ATE257381T1 (es)
AU (1) AU741362B2 (es)
CA (1) CA2274910C (es)
DE (2) DE19652188C2 (es)
DK (1) DK0949925T3 (es)
ES (1) ES2214649T3 (es)
NO (1) NO992907L (es)
PT (1) PT949925E (es)
WO (1) WO1998026780A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US7314716B2 (en) 1999-11-19 2008-01-01 Mount Sinai School Of Medicine Gustducin γ subunit materials and methods
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
EP1568346B1 (en) 2002-12-02 2016-06-22 Kyukyu Pharmaceutical Co., Ltd. Process for producing edible orally administered agent of laminate film form and compression bonding apparatus
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
JP4547994B2 (ja) 2004-06-02 2010-09-22 救急薬品工業株式会社 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤
DE102004045599A1 (de) * 2004-09-17 2006-03-23 Grünenthal GmbH System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen
DE102005007859A1 (de) * 2005-02-21 2006-08-24 Lts Lohmann Therapie-Systeme Ag Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
US9522188B2 (en) 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
EP1810669A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Darreichungsform für Buprenorphin
MX2009000745A (es) 2006-07-21 2009-04-16 Biodelivery Sciences Int Inc Dispositivos de suministro transmucosa con admision mejorada.
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
AU2011224107B2 (en) * 2006-08-30 2012-01-19 Euro-Celtique S.A. Buprenophine-wafer for drug substitution therapy
EP2123275A1 (en) * 2007-03-15 2009-11-25 Toyo Boseki Kabushiki Kaisha Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa
CN102056578A (zh) * 2008-06-23 2011-05-11 生物递送科学国际公司 多向粘膜给药装置及使用方法
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
CN103209681B (zh) 2010-06-10 2017-05-24 Mida科技有限公司 纳米颗粒薄膜递送系统
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
SG10202012743WA (en) * 2011-12-21 2021-01-28 Biodelivery Sciences Int Inc Transmucosal drug delivery devices for use in chronic pain relief
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CA3022840A1 (en) 2016-05-05 2017-11-09 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746414A1 (de) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Mittel zum dosieren von stoffen und verfahren zu seiner herstellung
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS58174307A (ja) * 1982-04-06 1983-10-13 Teikoku Seiyaku Kk 可食性口腔内貼付薬
JPS60116630A (ja) * 1983-11-29 1985-06-24 Nitto Electric Ind Co Ltd 口腔内製剤
GB8430346D0 (en) * 1984-11-30 1985-01-09 Reckitt & Colmann Prod Ltd Analgesic compositions
AU6541786A (en) * 1985-10-09 1987-05-05 Desitin Arzneimittel Gmbh Process for producing an administration or dosage form of drugs, reagents or other active ingredients
US4722928A (en) * 1985-12-02 1988-02-02 E. I. Du Pont De Nemours And Company N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
JPH07553B2 (ja) * 1985-12-09 1995-01-11 佐藤製薬株式会社 フイルム状製剤
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
JPH0653683B2 (ja) * 1988-07-14 1994-07-20 ザ ロックフェラー ユニバーシティ 慢性痛あるいは慢性咳を治療する経口用組成物
JP2879695B2 (ja) * 1990-02-22 1999-04-05 日本曹達株式会社 口腔内粘膜付着性フィルム製剤
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
JP3197035B2 (ja) * 1991-12-10 2001-08-13 積水化学工業株式会社 口腔粘膜適用製剤
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3731612B2 (ja) * 1995-04-21 2006-01-05 東洋紡績株式会社 口腔粘膜貼付ブプレノルフィン製剤

Also Published As

Publication number Publication date
NO992907D0 (no) 1999-06-14
JP2001506640A (ja) 2001-05-22
DK0949925T3 (da) 2004-04-05
EP0949925A2 (de) 1999-10-20
AU5653298A (en) 1998-07-15
WO1998026780A3 (de) 1998-08-27
DE19652188A1 (de) 1998-06-18
ES2214649T3 (es) 2004-09-16
JP2009242415A (ja) 2009-10-22
CA2274910A1 (en) 1998-06-25
KR100514306B1 (ko) 2005-09-13
AU741362B2 (en) 2001-11-29
CA2274910C (en) 2005-07-05
DE19652188C2 (de) 2002-02-14
DE59711194D1 (de) 2004-02-12
EP0949925B1 (de) 2004-01-07
ATE257381T1 (de) 2004-01-15
PT949925E (pt) 2004-05-31
WO1998026780A2 (de) 1998-06-25
KR20000057566A (ko) 2000-09-25

Similar Documents

Publication Publication Date Title
NO992907D0 (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
AU1227899A (en) Osmotic medicament releasing system
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
DE69921941D1 (de) Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln
GR910100283A (el) Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως.
AU1232600A (en) Dosage forms containing taste masked active agents
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
HUP0203733A2 (en) Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy
HUP0203590A2 (hu) Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
SE9700885D0 (sv) New pharmaceutical formulation
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO20020987L (no) Naturlig, fysiologisk aktivt stoff som er virksomt mot fiske- parasittisme, og fiskefôr inneholdende stoffet
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
AU5842300A (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU5816298A (en) Taste masking for unpalatable formulations
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
UA32598C2 (uk) Спосіб одержання лікарської форми карбамазепіну
SE0101258D0 (sv) Treatment of low back pain and whiplash associated disorder
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application